134 related articles for article (PubMed ID: 30938075)
1. Model-based monitoring of industrial reversed phase chromatography to predict insulin variants.
Roch P; Sellberg A; Andersson N; Gunne M; Hauptmann P; Nilsson B; Mandenius CF
Biotechnol Prog; 2019 Jul; 35(4):e2813. PubMed ID: 30938075
[TBL] [Abstract][Full Text] [Related]
2. Large scale purification and characterization of A21 deamidated variant-most prominent post translational modification (PTM) for insulins which is also widely observed in insulins pharmaceutical manufacturing and storage.
Shukla V; Srivatsa K; Madhu Kumar MS; Vajpai N; Agarwal N; Nethra S; Somesh BP; Kulshrestha A; Hazra P
Protein Expr Purif; 2021 Sep; 185():105895. PubMed ID: 33957255
[TBL] [Abstract][Full Text] [Related]
3. A parallel pore and surface diffusion model for predicting the adsorption and elution profiles of lispro insulin and two impurities in gradient-elution reversed phase chromatography.
Chung PL; Bugayong JG; Chin CY; Wang NH
J Chromatogr A; 2010 Dec; 1217(52):8103-20. PubMed ID: 21074775
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Modeling Based PAT Implementation for Ion-Exchange Process Chromatography of Charge Variants of Monoclonal Antibody Products.
Kumar V; Rathore AS
Biotechnol J; 2017 Sep; 12(9):. PubMed ID: 28731622
[TBL] [Abstract][Full Text] [Related]
5. Modeling and optimization of preparative reversed-phase liquid chromatography for insulin purification.
Degerman M; Jakobsson N; Nilsson B
J Chromatogr A; 2007 Aug; 1162(1):41-9. PubMed ID: 17376466
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic modeling of ion-exchange process chromatography of charge variants of monoclonal antibody products.
Kumar V; Leweke S; von Lieres E; Rathore AS
J Chromatogr A; 2015 Dec; 1426():140-53. PubMed ID: 26686559
[TBL] [Abstract][Full Text] [Related]
7. Pareto-optimal reversed-phase chromatography separation of three insulin variants with a solubility constraint.
Arkell K; Knutson HK; Frederiksen SS; Breil MP; Nilsson B
J Chromatogr A; 2018 Jan; 1532():98-104. PubMed ID: 29198837
[TBL] [Abstract][Full Text] [Related]
8. Modeling of preparative reversed-phase HPLC of insulin.
Liu X; Kaczmarski K; Cavazzini A; Szabelski P; Zhou D; Guiochon G
Biotechnol Prog; 2002; 18(4):796-806. PubMed ID: 12153314
[TBL] [Abstract][Full Text] [Related]
9. Digital twin of a continuous chromatography process for mAb purification: Design and model-based control.
Tiwari A; Masampally VS; Agarwal A; Rathore AS
Biotechnol Bioeng; 2023 Mar; 120(3):748-766. PubMed ID: 36517960
[TBL] [Abstract][Full Text] [Related]
10. Displacement effect during HPLC preparative purification of human insulin.
Gusarov D; Nekipelova V; Gusarova V; Lasman V; Bairamashvili D
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1216-20. PubMed ID: 19286429
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of potassium chloride and ethanol as mobile phase modulators on hydrophobic interaction and reversed-phase chromatography of three insulin variants.
Johansson K; Frederiksen SS; Degerman M; Breil MP; Mollerup JM; Nilsson B
J Chromatogr A; 2015 Feb; 1381():64-73. PubMed ID: 25595534
[TBL] [Abstract][Full Text] [Related]
12. [Method development of reversed-phase preparative liquid chromatography for insulin].
Pan J; Tao Y
Se Pu; 2017 Aug; 35(8):848-854. PubMed ID: 29048820
[TBL] [Abstract][Full Text] [Related]
13. Use of HPLC as an Enabler of Process Analytical Technology in Process Chromatography.
Tiwari A; Kateja N; Chanana S; Rathore AS
Anal Chem; 2018 Jul; 90(13):7824-7829. PubMed ID: 29847937
[TBL] [Abstract][Full Text] [Related]
14. Influence of the pore size of reversed phase materials on peptide purification processes.
Gétaz D; Dogan N; Forrer N; Morbidelli M
J Chromatogr A; 2011 May; 1218(20):2912-22. PubMed ID: 21450297
[TBL] [Abstract][Full Text] [Related]
15. Advances in inline quantification of co-eluting proteins in chromatography: Process-data-based model calibration and application towards real-life separation issues.
Brestrich N; Sanden A; Kraft A; McCann K; Bertolini J; Hubbuch J
Biotechnol Bioeng; 2015 Jul; 112(7):1406-16. PubMed ID: 25683378
[TBL] [Abstract][Full Text] [Related]
16. Expediting online liquid chromatography for real-time monitoring of product attributes to advance process analytical technology in downstream processing of biopharmaceuticals.
Graf T; Naumann L; Bonnington L; Heckel J; Spensberger B; Klein S; Brey C; Nachtigall R; Mroz M; Hogg TV; McHardy C; Martinez A; Braaz R; Leiss M
J Chromatogr A; 2024 Aug; 1729():465013. PubMed ID: 38824753
[TBL] [Abstract][Full Text] [Related]
17. Modelling and optimisation of preparative chromatographic purification of europium.
Ojala F; Max-Hansen M; Kifle D; Borg N; Nilsson B
J Chromatogr A; 2012 Jan; 1220():21-5. PubMed ID: 22189296
[TBL] [Abstract][Full Text] [Related]
18. Multiproduct Resin Reuse for Clinical and Commercial Manufacturing-Methodology and Acceptance Criteria.
Sharnez R; Doares S; Manning S; Mehta K; Mahajan E; To A; Daniels W; Glynn J; Dhamane S; Wen X; Wang Y; Gour P; Guenther C; Foley D; Hayes R; Mott A; Prabhu S; Tavalsky D; Hendershot M; Haas D; Hesslein A; Schuelke N; Tjandra H
PDA J Pharm Sci Technol; 2018; 72(6):584-598. PubMed ID: 30030349
[TBL] [Abstract][Full Text] [Related]
19. Effect of salt modulators on the elution behavior of insulin and the separation of product-related impurities in reversed-phase chromatography.
Koch J; Scheps D; Gunne M; Boscheinen O; Frech C
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1224():123735. PubMed ID: 37182410
[TBL] [Abstract][Full Text] [Related]
20. Methods for protecting silica sorbents used in high-performance liquid chromatography from strongly adsorbed impurities during purification of human recombinant insulin.
Gusarov D; Lasman V; Bayramashvili D
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):354-9. PubMed ID: 17349827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
